title: Therapeutic effect of tocilizumab on two patients with polymyositis.
authors.forename: Masashi
authors.initials: M
authors.lastname: Narazaki
authors.forename: Keisuke
authors.initials: K
authors.lastname: Hagihara
authors.forename: Yoshihito
authors.initials: Y
authors.lastname: Shima
authors.forename: Atsushi
authors.initials: A
authors.lastname: Ogata
authors.forename: Tadamitsu
authors.initials: T
authors.lastname: Kishimoto
authors.forename: Toshio
authors.initials: T
authors.lastname: Tanaka
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D017060:Patient Satisfaction; D017285:Polymyositis / Q000175:diagnosis* / Q000188:drug therapy*; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C502936:tocilizumab